Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N1HL
|
||||
Former ID |
DIB006724
|
||||
Drug Name |
Frakefamide
|
||||
Synonyms |
BCH-3963; LEF-553; LEF-576; SPD-759; LEF, AstraZeneca/BioChem Pharma
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Discontinued in Phase 2 | [546587] | ||
Company |
Shire plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C30H34FN5O5
|
||||
Canonical SMILES |
C(=O)(N[C@H](C(=O)N)Cc1ccccc1)[C@@H](NC(=O)[C@H](NC(=O)<br />[C@H](Cc1ccc(cc1)O)N)C)Cc1ccc(F)cc1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Agonist | [527449] | |
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.